DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats

Journal of Endocrinology

Volumn 218, Issue 1, 2013, Pages 1-11

  Pintana, Hiranya ^a   Apaijai, Nattayaporn ^a   Chattipakorn, Nipon ^a   Chattipakorn, Siriporn C ^a,b  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Brain mitochondrial; DDP 4 inhibitors; Dysfunction; High fat diet; Insulin resistance; Memory decline

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SITAGLIPTIN; VILDAGLIPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; BRAIN MITOCHONDRION; COGNITION; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; HIPPOCAMPUS; INSULIN RESISTANCE; LEARNING; LIPID DIET; LOCOMOTION; MALE; MAZE TEST; MEMORY; METABOLIC PARAMETERS; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OPEN FIELD BEHAVIOR; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

BRAIN MITOCHONDRIAL DYSFUNCTION; DDP-4 INHIBITORS; HIGH-FAT DIET; INSULIN RESISTANCE; MEMORY DECLINE;

ADAMANTANE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HIPPOCAMPUS; INSULIN RESISTANCE; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MITOCHONDRIA; NITRILES; OBESITY; OXIDATIVE STRESS; PYRAZINES; PYRROLIDINES; RATS; RATS, WISTAR; TRIAZOLES;

EID: 84878781836     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0521     Document Type: Article

References (43)

1. Aon MA, Cortassa S, Akar FG & O'Rourke B 2006 Mitochondrial criticality: a new concept at the turning point of life or death. Biochimica et Biophysica Acta 1762 232-240. (doi:10.1016/j.bbadis.2005.06.008)
2. Appleton DJ, Rand JS & Sunvold GD 2005 Basal plasma insulin and homeostasis model assessment (HOMA) are indicators of insulin sensitivity in cats. Journal of Feline Medicine and Surgery 7 183-193. (doi:10.1016/j.jfms.2004.12.002)
3. Arakawa H 2005 Age dependent effects of space limitation and social tension on open-field behavior in male rats. Physiology & Behavior 84 429-436. (doi:10.1016/j.physbeh.2005.01.008)
4. Baggio LL & Drucker DJ 2007 Biology of incretins: GLP-1 and GIP. Gastroenterology 132 2131-2157. (doi:10.1053/j.gastro.2007.03.054)
5. Burkey BF, Li X, Bolognese L, Balkan B, Mone M, Russell M, Hughes TE & Wang PR 2005 Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats. Journal of Pharmacology and Experimental Therapeutics 315 688-695. (doi:10.1124/jpet.105.087064)
6. Candan N & Tuzmen N 2008 Very rapid quantification ofmalondialdehyde (MDA) in rat brain exposed to lead, aluminium and phenolic antioxidants by high-performance liquid chromatography-fluorescence detection. Neurotoxicology 29 708-713. (doi:10.1016/j.neuro. 2008.04.012)
7. Chen B, Moore A, Escobedo LV, Koletsky MS, Hou D, Koletsky RJ, Ernsberger P 2011a Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats. Experimental Biology and Medicine 236 309-314. (doi:10.1258/ebm.2010.010161)
8. Chen S, Liu AR, An FM, Yao WB & Gao XD 2011b Amelioration of neurodegenerative changes in cellular and rat models of diabetesrelated Alzheimer's disease by exendin-4. Age 34 1211-1224. (doi:10.1007/s11357-011-9303-8)
9. D'Alessio DA, Kahn SE, Leusner CR & Ensinck JW 1994 Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. Journal of Clinical Investigation 93 2263-2266. (doi:10.1172/JCI117225)
10. D'Amico M, Di Filippo C, Marfella R, Abbatecola AM, Ferraraccio F, Rossi F & Paolisso G 2010 Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice. Experimental Gerontology 45 202-207. (doi:10.1016/j.exger.2009.12.004)
11. During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ et al. 2003 Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nature Medicine 9 1173-1179. (doi:10.1038/nm919)
12. Escribano L, Simon AM, Perez-Mediavilla A, Salazar-Colocho P, Del Rio J, Frechilla D 2009 Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model. Biochemical and Biophysical Research Communications 379 406-410. (doi:10.1016/j.bbrc.2008.12.071)
13. Green KN, Billings LM, Roozendaal B, McGaugh JL & LaFerla FM 2006 Glucocorticoids increase amyloid-b and tau pathology in a mousemodel of Alzheimer's disease. Journal of Neuroscience 26 9047-9056. (doi:10.1523/JNEUROSCI.2797-06.2006)
14. Greenwood CE & Winocur G 2005 High-fat diets, insulin resistance and declining cognitive function. Neurobiology of Aging 26(Suppl 1) 42-45. (doi:10.1016/j.neurobiolaging.2005.08.017)
15. Grotto D, Santa Maria LD, Boeira S, Valentini J, Charao MF, Moro AM, Nascimento PC, Pomblum VJ & Garcia SC 2007 Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography- visible detection. Journal of Pharmaceutical and Biomedical Analysis 43 619-624. (doi:10.1016/j.jpba.2006.07.030)
16. Haffner SM, Miettinen H & Stern MP 1997 The homeostasis model in the San Antonio Heart Study. Diabetes Care 20 1087-1092. (doi:10.2337/ diacare.20.7.1087)
17. Halestrap AP, Clarke SJ & Javadov SA 2004 Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovascular Research 61 372-385. (doi:10.1016/ S0008-6363(03)00533-9)
18. Holst JJ, Burcelin R & Nathanson E 2011 Neuroprotective properties of GLP-1: theoretical and practical applications. Current Medical Research and Opinion 27 547-558. (doi:10.1185/03007995.2010.549466)
19. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC & Butler PC 2004 Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53 474-481. (doi:10.2337/diabetes.53.2.474)
20. Kahn BB & Flier JS 2000 Obesity and insulin resistance. Journal of Clinical Investigation 106 473-481. (doi:10.1172/JCI10842)
21. Kastin AJ, Akerstrom V & Pan W 2002 Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. Journal of Molecular Neuroscience 18 7-14. (doi:10.1385/JMN:18:1-2:07)
22. Kim I, Lee J, Hong HJ, Jung ES, Ku YH, Jeong IK, Cho YM, So I, Park KS & Mook-Jung I 2010 A relationship between Alzheimer's disease and type 2 diabetes mellitus through the measurement of serum amyloid-b autoantibodies. Journal of Alzheimer's Disease 19 1371-1376. (doi: 10.3233/ JAD-2010-1332)
23. Perlmuter LC, Nathan DM, Goldfinger SH, Russo PA, Yates J & Larkin M 1988 Triglyceride levels affect cognitive function in noninsulindependent diabetics. Journal of Diabetes and its Complications 2 210-213. (doi:10.1016/S0891-6632(88)80011-4)
24. Petersen KF & Shulman GI 2006 Etiology of insulin resistance. American Journal of Medicine 119 S10-S16. (doi:10.1016/j.amjmed.2006.01.009)
25. Pintana H, Pintana H, Apaijai N, Pratchayasakul W, Chattipakorn N & Chattipakorn SC 2012 Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats. Life Sciences 91 409-414. (doi:10.1016/ j.lfs.2012.08.017)
26. Pipatpiboon N, Pratchayasakul W, Chattipakorn N & Chattipakorn SC 2012 PPARg agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets. Endocrinology 153 329-338. (doi:10.1210/en.2011-1502)
27. Pospisilik JA, Stafford SG, Demuth HU, McIntosh CH & Pederson RA 2002 Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study. Diabetes 51 2677-2683. (doi:10.2337/diabetes.51.9.2677)
28. Pratchayasakul W, Kerdphoo S, Petsophonsakul P, Pongchaidecha A, Chattipakorn N & Chattipakorn SC 2011 Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone. Life Sciences 88 619-627. (doi:10.1016/ j.lfs.2011.02.003)
29. Richter B, Bandeira-Echtler E, Bergerhoff K & Lerch CL 2008 Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews CD006739. (doi: 10.1002/14651858. CD006739)
30. Rosenstock J & Zinman B 2007 Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus. Current Opinion in Endocrinology, Diabetes, and Obesity 14 98-107. (doi:10.1097/MED. 0b013e3280a02f65)
31. Schafer M & Erdo SL 1991 Development of glutamate neurotoxicity in cortical cultures: induction of vulnerability by insulin. Brain Research Developmental Brain Research 62 293-296. (doi:10.1016/0165-3806 (91)90179-M)
32. Stranahan AM, Norman ED, Lee K, Cutler RG, Telljohann RS, Egan JM & MattsonMP 2008 Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 18 1085-1088. (doi:10.1002/hipo.20470)
33. Thummasorn S, Kumfu S, Chattipakorn S & Chattipakorn N 2011 Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria. Mitochondrion 11 457-466. (doi:10.1016/j.mito.2011.01.008)
34. Tomas E, Stanojevic V & Habener JF 2011 GLP-1-derived nonapeptide GLP-1(28-36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes. Regulatory Peptides 167 177-184. (doi:10.1016/j.regpep.2011.01.003)
35. Tsuboi T, da Silva Xavier G, Holz GG, Jouaville LS, Thomas AP & Rutter GA 2003 Glucagon-like peptide-1 mobilizes intracellular Ca2C and stimulates mitochondrial ATP synthesis in pancreatic MIN6 b-cells. Biochemical Journal 369 287-299. (doi:10.1042/BJ20021288)
36. Vaghasiya J, Sheth N, Bhalodia Y & Manek R 2010 Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes. Regulatory Peptides 166 48-54. (doi:10.1016/j.regpep.2010.08.007)
37. Valladolid-Acebes I, Stucchi P, Cano V, Fernandez-Alfonso MS, Merino B, Gil-Ortega M, Fole A, Morales L, Ruiz-Gayo M & Del Olmo N 2011 High-fat diets impair spatial learning in the radial-arm maze in mice. Neurobiology of Learning and Memory 95 80-85. (doi:10.1016/j.nlm. 2010.11.007)
38. Vorhees CV & Williams MT 2006 Morris Water Maze: procedures for assessing spatial and related forms of learning and memory. Nature Protocols 1 848-858. (doi:10.1038/nprot.2006.116)
39. Wang BW, Hok V, Della-Chiesa A, Callaghan C, Barlow S, Tsanov M, Bechara R, Irving E, Virley DJ, Upton N et al. 2011 Rosiglitazone enhances learning, place cell activity, and synaptic plasticity in middleaged rats. Neurobiology of Aging 835 e813-e830. (doi: 10.1016/ j.neurobiolaging.2011.08.013)
40. White CL, Pistell PJ, Purpera MN, Gupta S, Fernandez-Kim SO, Hise TL, Keller JN, Ingram DK, Morrison CD, Bruce-Keller AJ 2009 Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal diet. Neurobiological Disorders 35 3-13. (doi: 10.1016/j.nbd.2009.04.002)
41. Winocur G, Greenwood CE, Piroli GG,Grillo CA, Reznikov LR, Reagan LP & McEwen BS 2005 Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behavioral Neuroscience 119 1389-1395. (doi:10.1037/0735-7044.119.5.1389)
42. Zhao WQ & Townsend M 2009 Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Biochimica et Biophysica Acta 1792 482-496. (doi:10.1016/ j.bbadis.2008.10.014)
43. Zorov DB, Juhaszova M & Sollott SJ 2006 Mitochondrial ROS-induced ROS release: an update and review. Biochimica et Biophysica Acta 1757 509-517. (doi:10.1016/j.bbabio.2006.04.029)